AM Ansari

Ophthalmologist

[Dr Dhiman Bhattacharya 🇮🇳 🇮🇳 🇮🇳 @DrdhimanBhatta1]

There are no shortcuts to consistent outperformance.
@BaapofOption

Retweet for maximum reach.

Screens can scan.
AI can assist.
But conviction comes from doing the work yourself.

Manual analysis builds understanding.
Understanding builds conviction. Conviction creates big winners.

Simple but not easy.

[Dr Dhiman Bhattacharya 🇮🇳 🇮🇳 🇮🇳 @DrdhimanBhatta1]

5 takeaways from last night's Fed meeting:

1️⃣ Fed kept interest rates unchanged, as expected.

2️⃣ Policymakers signaled a more hawkish stance, with higher inflation still a concern.

3️⃣ Rate cuts are no longer guaranteed; some officials now see the possibility of hikes later this year.

4️⃣ Bond yields and the US dollar strengthened, while equities reacted negatively.

5️⃣ For investors, liquidity remains tight—quality assets, strong earnings and disciplined asset allocation matter more than chasing momentum.

MARKET MAY REACT ON EITHER SIDE DEPENDING ON FUTURE FED ACTIVITIES.

[AM Ansari @AMAnsari2004]

@DrdhimanBhatta1 @in_tradingview
I Abdul Mukit Ansari ([phone],[email protected])
brought essential subscriptions of Trading View recently.Since then I am not accessible to real time data but previously it was without any subscription.please help me out.

[AM Ansari @AMAnsari2004]

@DrdhimanBhatta1 @in_tradingview
I Abdul Mukit Ansari ([phone],[email protected])
brought essential subscriptions of Trading View recently.Since then I am not accessible to real time data but previously it was without any subscription.please help me out.

[AM Ansari @AMAnsari2004]

@DrdhimanBhatta1 @tradingview
I Abdul Mukit Ansari,([phone],[email protected])upgraded to Essential plan recently but after upgrading,not been able to use realtime data which was accessible previously without any subscription.Please help me out.

[Dr Dhiman Bhattacharya 🇮🇳 🇮🇳 🇮🇳 @DrdhimanBhatta1]

Why Momentum Investing Beats Value Investing in India?
@BaapofOption
@Sharad9Dubey
For decades, investors were taught to buy cheap stocks and wait for the market to recognize their value.

But what if the market rewards strength more than cheapness?

Please RETWEET FOR MAXIMUM REACH.

A recent study compared traditional value investing (Piotroski & Graham portfolios) with the Nifty 200 Momentum 30 strategy.

The results were eye-opening.

5-Year CAGR 👇

• Nifty 200: 7.53%
• Piotroski Value Portfolio: 13.12%
• Graham Value Portfolio: 16.61%
• Nifty 200 Momentum 30: 20.79%

A ₹10 lakh investment would have grown roughly:

• ₹14.4 lakh in Nifty 200 ONLY.
• ₹25.7 lakh in Nifty 200 Momentum 30!

That's nearly 3 times the wealth creation.

Why Momentum Works?

Momentum investing doesn't try to predict the future.

It simply identifies stocks already showing strong price performance and institutional demand.

The strategy:

1. Starts with Nifty 200 stocks.
2. Measures 6-month and 12-month returns.
3. Selects the strongest performers.
4. Rebalances every six months.

No forecasting.

No valuation assumptions.

No guesswork.

Just following market leadership.

The Problem With Value Investing 👇:

Cheap stocks often remain cheap for a reason.

Many value investors fall into "value traps"—companies that appear undervalued but suffer from weak growth, poor management, or declining industries.

The study showed that both value portfolios suffered severe first-year drawdowns:

• Piotroski: -41.49%
• Graham: -46.93%

Most investors would struggle to stay invested through losses of that magnitude.

Intolerable! Isn't it?

Momentum avoids many of these traps by demanding one thing:

Price strength.

Why Momentum Is Especially Powerful In India?

India is a fast-growing economy driven by:

• Banking
• Manufacturing
• Defence
• Capital Goods
• Financialization and so on.

The strongest businesses attract more capital, more earnings growth, and more investor attention.

Momentum naturally identifies these winners.

Value investing often misses them because great businesses rarely look cheap.

The Big Lesson::

Value investing assumes the market is wrong.

Momentum investing assumes the market may know something you don't.

This study suggests that investors searching for long-term wealth creation should spend less time looking for cheap stocks and more time identifying market leaders.

In investing, strength is often the ultimate value.

Please RETWEET.

[Dr Dhiman Bhattacharya 🇮🇳 🇮🇳 🇮🇳 @DrdhimanBhatta1]

THE MARKET JUST GOT A MASSIVE PLOT TWIST.
Retweet for maximum reach.

While everyone was panic-buying headlines, one geopolitical development may have changed the direction of oil, gold, silver, and Indian equities.

Let's connect the dots. 🧵👇

1/ The biggest story isn't the Fed.

It's the reported US-Iran agreement.

If this deal survives the signature stage, the world may have just dodged a major energy shock.

And markets know it.

2/ Oil traders were pricing fear.

Fear of disruption.
Fear of Hormuz closure.
Fear of supply shortages.

Now?

Brent and WTI have rapidly surrendered much of their conflict premium.

Translation: the market is betting on normalization.

3/ Here's where it gets interesting.

The Hormuz Strait handles a huge chunk of global energy movement.

Even partial normalization means:

✅ More oil supply
✅ Lower freight stress
✅ Reduced inflation pressure

One signature could affect everything from your petrol bill to central-bank policy.

4/ The hidden winner?

India.

A lower crude basket means:

• Reduced import pressure
• Better inflation outlook
• Potential support for corporate margins

Many investors are missing this second-order effect.

5/ Now let's talk about gold.

Everyone expected gold to collapse if tensions eased.

It didn't.

That's your clue.

Strong assets don't crash on good news.

They absorb it.

Gold appears to be building a major base rather than entering a bear market.

6/ Silver is even more fascinating.

While gold hesitated...

Silver exploded higher.

It reclaimed key technical levels and continues showing stronger relative strength.

Smart money watches relative strength before headlines catch up.

7/ Why is silver behaving differently?

Because silver isn't just a precious metal.

It's also an industrial metal.

If economic fears fade while liquidity expectations improve, silver gets two engines instead of one.

That's a powerful setup.

8/ But here's the real seduction...

The Fed meeting.

Every trader wants to know:

Will they cut?
Pause?
Or stay hawkish?

One sentence from Powell can move:

• Gold
• Silver
• Bonds
• Dollar
• Stocks

Simultaneously.

9/ The Fed faces a nasty dilemma.

Cut rates → inflation risk.

Hold rates → growth risk.

Support bonds → liquidity consequences.

Fight inflation → economic slowdown risk.

There are no painless choices left.

10/ Meanwhile, global markets are quietly voting.

Japanese equities surged.

US futures jumped.

Risk appetite returned almost overnight.

Markets love certainty more than they love good news.

11/ What about India?

Here's the uncomfortable truth.

India hasn't participated in the same explosive rally seen in some Asian markets.

That's exactly why long-term investors should pay attention.

Sometimes the best opportunities are where excitement is missing.

12/ Chasing stocks making fresh vertical moves is usually a wealth-destroying hobby.

The smarter game:

Find fundamentally strong businesses.

Buy them near major support levels.

Then let time do the heavy lifting.

13/ My biggest takeaway:

The market's narrative may be changing from:

"Geopolitical crisis"

to

"Disinflation + normalization."

If that transition continues, today's headlines could look very different 6 months from now.

14/ Watch these 3 things closely this week:

👀 Oil
👀 Gold/Silver
👀 Fed commentary

They may tell you more about the next market move than any TV expert.

The loudest story is rarely the most important one.

The quiet shift underneath usually is.
R U READY?

#Nifty #Gold #Silver #Fed #Investing #StockMarket #Oil
#mundialdefútbol2026 #TrumpRally #IranWar‌ #IranStrikes

[Mark Minervini Quotes @MinerviniQuote]

"Dedication and a desire to succeed are definitely requirements to achieve superperformance in stocks. What is not required is conventional wisdom or a college education."

[Dr Dhiman Bhattacharya 🇮🇳 🇮🇳 🇮🇳 @DrdhimanBhatta1]

Is #JPMorgan Walking the Lehman BROTHERS Way?

@Sharad9Dubey
Please RETWEET FOR MAXIMUM REACH.
@sjlazars

Most people believe financial crises start with sudden collapse.
That’s wrong!
@AstroCounselKK

They start with stress fractures in markets that most people don’t watch!
@WeekendInvestng

👉 Silver is one such market.
@cmagurvinder

1️⃣ The Silver Crash That Wasn’t “Normal”:

Silver just experienced its most violent intraday crash in 46 years — down nearly 35% intraday in a single Friday session!
#silvercrash

This was not routine volatility.
This magnitude of a move hasn’t been seen since the Hunt Brothers era!
#SilverRate

Yet here’s the paradox 👇

Despite this historic smash, silver closed January UP ~19%, marking 9 consecutive positive months!

👉 That alone tells you: this is not a bubble blow-off. 🙌

2️⃣ Structural Strength vs Paper Panic:

Bubbles don’t survive crashes like this.
Structural bull markets do.

A market that:
Crashes violently intraday,
Yet closes the month strongly positive,
And keeps rising for 9 straight months
…is not being driven by retail euphoria.

It’s being driven by supply stress.

3️⃣ JPMorgan’s “Perfect Timing” Is the Red Flag 🚩:

Now comes the uncomfortable part.

JPMorgan Chase & Co. reportedly closed nearly 2,000 silver short positions!

🎯 exactly at $75/oz — the precise bottom of the crash!!!!!

Let that sink in.

Retail was panicking!

Algorithms were liquidating!

Headlines screamed “collapse”
And JPMorgan exited shorts at the exact low!
#silversqueeze
This was not luck!

This was inside knowledge of market mechanics.

4️⃣ Why This Resembles Lehman?

Lehman didn’t collapse because of housing alone.

It collapsed because:
It was overexposed

The paper market diverged from reality

Liquidity vanished before

insolvency was admitted

Silver today shows the same warning signs: (IMPORTANT):

Paper silver collapsing

Physical silver becoming unavailable

Institutions scrambling to reposition quietly

History doesn’t repeat — it rhymes.

5️⃣ The Perth Mint Event Everyone Ignored!

Before the crash even happened…
👉 Perth Mint
suspended sales of 1oz silver Kangaroo coins due to overwhelming demand!

This is crucial.

Physical silver didn’t become scarce after the crash.

It was already breaking before prices collapsed!

That means:
Real metal was disappearing While paper prices were being smashed!

That is systemic stress, not speculation.

6️⃣ Paper Silver vs Physical Silver: The Breaking Point.

Here is the core issue, explained simply:

Paper silver = infinite contracts.
Physical silver = finite metal.

When:
Paper prices crash
But physical demand explodes
And mints start rationing
👉 The system becomes unstable.

Some institutions cannot deliver metal at paper prices!
That’s how insolvency begins — quietly.

7️⃣ If a Major Bank Is in Trouble, What Happens Next?

Banks don’t fail publicly first.
They fail politically first!

If silver exposure is threatening balance sheets:

Expect government intervention.
Expect price suppression attempts.
Expect media silence.

But also expect:
Physical premiums to spike.
Metal to disappear, Delivery delays.

This is exactly what early warning phases look like!

8️⃣ Final Thought (Read This Twice):

I am not saying JPMorgan will collapse.
I am saying:
JPMorgan is behaving the way institutions behave
when they know a manipulation cycle has reached its limit.
They exited shorts at the bottom.
Retail was shaken out.
Physical silver is vanishing.
THAT HAPPENED IN 2008 CRISIS WHEN #StockMarketCrash took place!

📌 The bull market in silver is intact.

📌 The manipulation game has hit its structural limit.

📌 The next meaningful move is upward — not because of hype, but because of physics.

Thank you for your time 😊🙏.
Please RETWEET.
#silveretf
#silverbees

[Dr Dhiman Bhattacharya 🇮🇳 🇮🇳 🇮🇳 @DrdhimanBhatta1]

Job data in #USA has come up very Good.

But remember one thing.
This is due to temporary jobs for #Football #FIFAWorldCup2026 in the country of #Trump !

So, focus on #Gold and #Silver along with #StocksToBuy !
#niftyfifty
#Nasdaq
#USDRUB
#stockmarkettrader
#FootballTwitter

[Dr Dhiman Bhattacharya 🇮🇳 🇮🇳 🇮🇳 @DrdhimanBhatta1]

Attention long term investors of gold and SILVER.
Your time has come.
That's the tweet.

[Dr Dhiman Bhattacharya 🇮🇳 🇮🇳 🇮🇳 @DrdhimanBhatta1]

What happens when bacteria become resistant to almost everything doctors can throw at them?

People die.

Not because medicine doesn't exist.

But because the medicine stops working!!

Please RETWEET FOR MAXIMUM REACH.

#Wockpharma

That's why Zaynich could be one of the most important drug approvals for India in years.

🧬 Zaynich combines cefepime with zidebactam, a novel enhancer designed to attack some of the world's most dangerous antibiotic-resistant Gram-negative bacteria, including:

▪ Klebsiella
▪ Pseudomonas
▪ Acinetobacter
▪ Stenotrophomonas

These are the pathogens that keep infectious disease specialists awake at night.

🇮🇳 Yesterday, India's CDSCO approved Zaynich.

🇺🇸 Today, it appears on the US FDA's Novel Drug Approvals list (29 May 2026).

Let that achievement sink in.

India is known as the pharmacy of the world.

But manufacturing medicines discovered elsewhere is one thing.

Discovering, developing, clinically testing and obtaining US FDA approval for a novel patented drug is an entirely different league.

For Wockhardt shareholders, the question has changed:

❌ Will it get approved?

✅ How big can it become?

The next milestones to watch:

▪ FDA label details
▪ US launch strategy
▪ Hospital adoption
▪ Physician acceptance
▪ Pricing & reimbursement
▪ Revenue ramp

Important:

FDA approval does NOT guarantee commercial success.

Many approved drugs fail commercially.

But after years of science, trials, setbacks and regulatory scrutiny, Wockhardt has crossed the hurdle that most drug developers never reach.

The science has largely been validated.

Now begins the business story.

Stock is trading at all time high.

Not a recommendation for educational purposes ONLY.
#Wockhardt

Please let me know your opinion 👇.

[AM Ansari @AMAnsari2004]

Obviously Sir

[Dr Dhiman Bhattacharya 🇮🇳 🇮🇳 🇮🇳 @DrdhimanBhatta1]

CANADA
IRELAND
ROMANIA

OFFICIALLY ARE IN RECESSION.
VERY HARD TIMES COMING.

[Dr Dhiman Bhattacharya 🇮🇳 🇮🇳 🇮🇳 @DrdhimanBhatta1]

CANADA
IRELAND
ROMANIA

OFFICIALLY ARE IN RECESSION.
VERY HARD TIMES COMING.

[Dr Dhiman Bhattacharya 🇮🇳 🇮🇳 🇮🇳 @DrdhimanBhatta1]

I am honored to be ranked among the Top 20 Investing Gurus Worldwide on #Topmate .

Please RETWEET FOR MAXIMUM REACH.

Thank you from the bottom of my heart to every student, reader, follower, and professional who has trusted my judgment, sought my guidance, and engaged with my work.
#investor

Your trust and consistency make this recognition meaningful.
I will continue to uphold the highest standards of clarity, discipline, and integrity in financial education.
#TradingStrategy

Together, we will keep elevating the way India — and the world — thinks about investing.
#Retirementplanning

https://t.co/uFdt6Eboa3

[AM Ansari @AMAnsari2004]

What happens when bacteria become resistant to almost everything doctors can throw at them?

People die.

Not because medicine doesn't exist.

But because the medicine stops working!!

Please RETWEET FOR MAXIMUM REACH.

#Wockpharma

That's why Zaynich could be one of the most important drug approvals for India in years.

🧬 Zaynich combines cefepime with zidebactam, a novel enhancer designed to attack some of the world's most dangerous antibiotic-resistant Gram-negative bacteria, including:

▪ Klebsiella
▪ Pseudomonas
▪ Acinetobacter
▪ Stenotrophomonas

These are the pathogens that keep infectious disease specialists awake at night.

🇮🇳 Yesterday, India's CDSCO approved Zaynich.

🇺🇸 Today, it appears on the US FDA's Novel Drug Approvals list (29 May 2026).

Let that achievement sink in.

India is known as the pharmacy of the world.

But manufacturing medicines discovered elsewhere is one thing.

Discovering, developing, clinically testing and obtaining US FDA approval for a novel patented drug is an entirely different league.

For Wockhardt shareholders, the question has changed:

❌ Will it get approved?

✅ How big can it become?

The next milestones to watch:

▪ FDA label details
▪ US launch strategy
▪ Hospital adoption
▪ Physician acceptance
▪ Pricing & reimbursement
▪ Revenue ramp

Important:

FDA approval does NOT guarantee commercial success.

Many approved drugs fail commercially.

But after years of science, trials, setbacks and regulatory scrutiny, Wockhardt has crossed the hurdle that most drug developers never reach.

The science has largely been validated.

Now begins the business story.

Stock is trading at all time high.

Not a recommendation for educational purposes ONLY.
#Wockhardt

Please let me know your opinion 👇.

[AM Ansari @AMAnsari2004]

#GEVernova T&D (GVT&D) – Deep Dive analysis:
@BaapofOption

Please RETWEET FOR MAXIMUM REACH.
@AstroCounselKK

1️⃣ Strong Earnings Momentum (Core Trigger):

Quarterly EPS has consistently beaten estimates from Q4’24 to Q3’25.
The latest quarter shows the widest positive surprise, confirming operational leverage and execution strength—not a one-off spike.
@sjlazars

2️⃣ Revenue & Profit Inflection Confirmed:

FY revenue ~₹43 bn with net income ~₹6 bn indicates margin expansion phase. This is classic late-cycle infra behavior where fixed costs flatten and operating profit accelerates.

3️⃣ Valuation: Expensive but Explained:

TTM P/E ~79 looks optically high, but markets are pricing a multi-year power capex upcycle, not current earnings.
This is earnings re-rating, not speculative froth—as long as growth sustains.

4️⃣ Volume Confirms Institutional Participation:

Current volume ~1.46M vs 30-day avg ~0.78M = ~2× surge. Breakouts with volume expansion rarely fail immediately.
This is smart money validation, not retail noise.

5️⃣ Clean Trend Reversal on Daily Chart:

Price reclaimed EMA 50, 100 & 200 decisively.
EMA alignment is now bullish (short > long), signaling trend transition from correction to expansion.

6️⃣ V-Shaped Recovery with Strength:

From ~₹2,550 lows to ~₹3,550 in weeks = strong hands accumulation.
Weak stocks retrace slowly; strong stocks snap back violently—this one did the latter.

7️⃣ Beta 1.65 = Momentum Stock, Not a Sleepy Utility:

High beta confirms alpha behavior.
Expect volatility, but also outsized upside during bull phases. This is not for conservative dividend hunters.

8️⃣ Dividend Yield Irrelevant(and That’s Fine):

Yield ~0.15% signals cash is being reinvested, not returned. In capex upcycles, reinvestment > dividends.
MARKET clearly agrees!

9️⃣ Sector Tailwind Is Structural, Not Cyclical:

India’s power transmission, renewables evacuation, grid upgrades & HVDC projects create a long visibility order book. GVT&D sits exactly at this intersection.

🔟 Risk Management & Levels (Crucial): Important, bookmark IT:

– Near-term resistance: ₹3,650–3,700
– Support zone: ₹3,050–3,100 (EMA cluster)
– Trend invalidation only below ₹2,950 on closing basis.

Bottom Line:

GVT&D is expensive, strong, and institutionally owned—a classic leader stock in an infra bull cycle. As long as earnings momentum holds, price will justify valuation.

"This is a trend-following buy, not a value buy."

Not an investment advice,for educational purposes ONLY.
#StocksToTrade
#StocksInFocus
#Stockstobuy
#StockMarketIndia
Remember:
Risk management > opinions.

Thank you for your time 🙏.
Please RETWEET.

[AM Ansari @AMAnsari2004]

There is nothing like losing all you have in the world for teaching you what not to do. And when you know what not to do in order not to lose money, you begin to learn what to do in order to win. Did you get that? You begin to learn!

[AM Ansari @AMAnsari2004]

If India truly wants massive long-term domestic & foreign capital inflow, the solution is simple:

• Zero LTCG
• 5% STCG
• Zero STT

Today FIIs are not leaving only because of valuations!

They are leaving because India is slowly becoming a taxation-heavy market compared to competing economies.

High transaction taxes reduce liquidity, participation, risk-taking & long-term wealth creation.

Punishing investors is not the path to making India a global financial superpower.

Make investing attractive again. Capital goes where it is respected.

Please RETWEET FOR MAXIMUM REACH.

[AM Ansari @AMAnsari2004]

To stay in share market he/she must have believe in himself/herself and own judgements,not on others tips.If anyone buys on others tip,he/she have to wait for tip from that man to https://t.co/28cgswWS8f can never beat own judgement.We have to trade independently.